Literature DB >> 27787643

Tinea Unguium: Diagnosis and Treatment in Practice.

Daniel Asz-Sigall1, Antonella Tosti2, Roberto Arenas3.   

Abstract

Onychomycosis is caused by dermatophytes, yeasts or non-dermatophyte molds; when caused by dermatophytes, it is called tinea unguium. The main etiological agents are Trichophyton rubrum and Trichophyton interdigitale. The most frequent types are distal and lateral subungual onychomycosis. Diagnosis usually requires mycological laboratory confirmation. Dermoscopy can be helpful and also biopsy is an excellent diagnostic method in uncommon cases or when mycological test is negative. Treatment must be chosen according to clinical type, number of affected nails and severity. The goal for antifungal therapy is the clearing of clinical signs or mycological cure.

Entities:  

Keywords:  Antifungal therapy; Dermatophytes; Dermoscopy; Onychomycosis; Tinea unguium

Mesh:

Substances:

Year:  2016        PMID: 27787643     DOI: 10.1007/s11046-016-0078-4

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  20 in total

Review 1.  Onychomycosis: Diagnosis and management.

Authors:  Archana Singal; Deepshikha Khanna
Journal:  Indian J Dermatol Venereol Leprol       Date:  2011 Nov-Dec       Impact factor: 2.545

2.  Mycological studies of nail samples obtained by curettage vs. vertical perforation of the nail plate.

Authors:  J M Rios-Yuil; A Bonifaz; R Arenas; J Araiza; R Fernández; P Mercadillo-Pérez; R Ponce-Olivera
Journal:  J Eur Acad Dermatol Venereol       Date:  2012-11-20       Impact factor: 6.166

Review 3.  Laser therapies for onychomycosis - critical evaluation of methods and effectiveness.

Authors:  W Francuzik; K Fritz; C Salavastru
Journal:  J Eur Acad Dermatol Venereol       Date:  2016-03-08       Impact factor: 6.166

4.  [Analysis of genetic polymorphism of the HLA-B and HLA-DR loci in patients with dermatophytic onychomycosis and in their first-degree relatives].

Authors:  M T García-Romero; J Granados; M E Vega-Memije; R Arenas
Journal:  Actas Dermosifiliogr       Date:  2011-07-13

5.  A method for the determination of drug effectiveness in onychomycosis. Trials with ketoconazole and griseofulvin ultramicrosize.

Authors:  N Zaias; D Drachman
Journal:  J Am Acad Dermatol       Date:  1983-12       Impact factor: 11.527

6.  Nail digital dermoscopy (onychoscopy) in the diagnosis of onychomycosis.

Authors:  B M Piraccini; R Balestri; M Starace; G Rech
Journal:  J Eur Acad Dermatol Venereol       Date:  2011-11-01       Impact factor: 6.166

7.  Onychomycosis: a proposed revision of the clinical classification.

Authors:  Roderick J Hay; Robert Baran
Journal:  J Am Acad Dermatol       Date:  2011-04-17       Impact factor: 11.527

Review 8.  Fungal melanonychia.

Authors:  Justin Finch; Roberto Arenas; Robert Baran
Journal:  J Am Acad Dermatol       Date:  2012-01-17       Impact factor: 11.527

Review 9.  Novel investigational therapies for onychomycosis: an update.

Authors:  Aditya K Gupta; Catherine Studholme
Journal:  Expert Opin Investig Drugs       Date:  2016       Impact factor: 6.206

10.  Dermoscopic patterns in patients with a clinical diagnosis of onychomycosis-results of a prospective study including data of potassium hydroxide (KOH) and culture examination.

Authors:  Miriam América Jesús-Silva; Ramón Fernández-Martínez; Rodrigo Roldán-Marín; Roberto Arenas
Journal:  Dermatol Pract Concept       Date:  2015-04-30
View more
  10 in total

1.  Dermatophytes and Dermatophytoses: A Thematic Overview of State of the Art, and the Directions for Future Research and Developments.

Authors:  J P Bouchara; B Mignon; V Chaturvedi
Journal:  Mycopathologia       Date:  2017-02       Impact factor: 2.574

2.  Comparative Study of Traditional Ablative CO2 Laser-Assisted Topical Antifungal with only Topical Antifungal for Treating Onychomycosis: A Multicenter Study.

Authors:  Bhavana Rajbanshi; Liangliang Shen; Miao Jiang; Qingyu Gao; Xin Huang; Jiaoyang Ma; Jihong Wang; Yang Hu; Hongli Lv; Xiao Wu; Jingjun Zhao
Journal:  Clin Drug Investig       Date:  2020-06       Impact factor: 2.859

3.  Fungal infections of the feet in patients with erysipelas of the lower limb: is it a significant clinical problem?

Authors:  Katarzyna Korecka; Dominik Mikiel; Agnieszka Banaszak; Anna Neneman
Journal:  Infection       Date:  2021-02-03       Impact factor: 3.553

4.  Cold Atmospheric Pressure Plasma Jet Reduces Trichophyton rubrum Adherence and Infection Capacity.

Authors:  Aline Chiodi Borges; Thalita Mayumi Castaldelli Nishime; Sabrina de Moura Rovetta; Gabriela de Morais Gouvêa Lima; Konstantin Georgiev Kostov; Gilmar Patrocínio Thim; Beatriz Rossi Canuto de Menezes; João Paulo Barros Machado; Cristiane Yumi Koga-Ito
Journal:  Mycopathologia       Date:  2019-08-30       Impact factor: 2.574

Review 5.  Epidemiology and Diagnostic Perspectives of Dermatophytoses.

Authors:  Monise Fazolin Petrucelli; Mariana Heinzen de Abreu; Bruna Aline Michelotto Cantelli; Gabriela Gonzalez Segura; Felipe Garcia Nishimura; Tamires Aparecida Bitencourt; Mozart Marins; Ana Lúcia Fachin
Journal:  J Fungi (Basel)       Date:  2020-11-23

6.  Cold atmospheric pressure plasma (CAPP) as a new alternative treatment method for onychomycosis caused by Trichophyton verrucosum: in vitro studies.

Authors:  Sebastian Gnat; Dominik Łagowski; Mariusz Dyląg; Jessica Zielinski; Marek Studziński; Aneta Nowakiewicz
Journal:  Infection       Date:  2021-09-09       Impact factor: 3.553

7.  Prevalence of superficial-cutaneous fungal infections in Shiraz, Iran: A five-year retrospective study (2015-2019).

Authors:  Hossein Khodadadi; Kamiar Zomorodian; Hasti Nouraei; Zahra Zareshahrabadi; Sajjad Barzegar; Mohammad Reza Zare; Keyvan Pakshir
Journal:  J Clin Lab Anal       Date:  2021-05-24       Impact factor: 2.352

8.  The Oomycete Pythium oligandrum Can Suppress and Kill the Causative Agents of Dermatophytoses.

Authors:  Alena Gabrielová; Karel Mencl; Martin Suchánek; Radim Klimeš; Vít Hubka; Miroslav Kolařík
Journal:  Mycopathologia       Date:  2018-07-02       Impact factor: 2.574

9.  NP213 (Novexatin®): A unique therapy candidate for onychomycosis with a differentiated safety and efficacy profile.

Authors:  Derry K Mercer; Jennifer C Robertson; Lorna Miller; Colin S Stewart; Deborah A O'Neil
Journal:  Med Mycol       Date:  2020-11-10       Impact factor: 4.076

10.  Inactivation of Dermatophytes Causing Onychomycosis and Its Therapy Using Non-Thermal Plasma.

Authors:  Jaroslav Lux; Radim Dobiáš; Ivana Kuklová; Radek Litvik; Vladimír Scholtz; Hana Soušková; Josef Khun; Jakub Mrázek; Michaela Kantorová; Pavla Jaworská; Táňa Prejdová; Jana Šnupárková; Petr Hamal; Jaroslav Julák
Journal:  J Fungi (Basel)       Date:  2020-10-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.